Research map: Retinal AI Risk Stratification and Cardiovascular Event Yield Across QRISK3 Categories in UK Biobank

Back to the article

Papers in this map

  1. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials · Cholesterol Treatment Trialists’ Collaboration · 2010 · 6580 citations · Cited by this paper
  2. Impact of High-sensitivity C-reactive protein testing on statin use in primary prevention: A national multicenter analysis · 2026 · Related
  3. Comparison of Sociodemographic and Health-Related Characteristics of UK Biobank Participants With Those of the General Population · Anna Fry · 2017 · 4403 citations · Cited by this paper
  4. Association of reproductive factors with acute myocardial infarction in young women: A VIRGO and NHANES case-control study · 2026 · Related
  5. Validation of a deep-learning-based retinal biomarker (Reti-CVD) in the prediction of cardiovascular disease: data from UK Biobank · Rachel Marjorie Wei Wen Tseng · 2023 · 65 citations · Cited by this paper
  6. Incretin therapy prescription in a high cardiovascular risk population: Insights from a cardiology-based cardiometabolic program · 2026 · Related
  7. Statin initiations and QRISK2 scoring in UK general practice: a THIN database study · Samuel Finnikin · 2017 · 56 citations · Cited by this paper
  8. Beyond place: Neighborhood deprivation, cardiometabolic health, and the life course origins of hypertensive disorders of pregnancy · 2026 · Related
  9. Independent external validation of the QRISK3 cardiovascular disease risk prediction model using UK Biobank · Ruth E. Parsons · 2023 · 51 citations · Cited by this paper
  10. Absence of significant coronary artery disease does not eliminate smoking-related cardiovascular risk: insights from the PROMISE trial · 2026 · Related
  11. Pivotal trial of a deep-learning-based retinal biomarker (Reti-CVD) in the prediction of cardiovascular disease: data from CMERC-HI · Chan Joo Lee · 2023 · 46 citations · Cited by this paper
  12. Don’t sleep on the other beds: Atherosclerosis across heart, brain, and limbs · 2026 · Related
  13. Prognostic potentials of AI in ophthalmology: systemic disease forecasting via retinal imaging · Yong Yu Tan · 2024 · 45 citations · Cited by this paper
  14. Prevalence and predictors of silent atherosclerosis across life: Design of the REACT Phase 1 study · 2026 · Related
  15. Cardiovascular disease risk assessment using a deep-learning-based retinal biomarker: a comparison with existing risk scores · Joseph Keunhong Yi · 2023 · 43 citations · Cited by this paper
  16. Real-world prescribing patterns of SGLT2 inhibitors and GLP-1 receptor agonists in Type 2 diabetes with various ASCVD subtypes from a large tertiary referral center · 2026 · Related
  17. Cardiovascular disease — risk assessment and reduction: NICE 2023 update for GPs · Emily M. Williams · 2024 · 7 citations · Cited by this paper
  18. Effectiveness of Yoga-based guided meditation In Improving the quality of sleep in patients with coronary artery disease: The Yoga Nidra Trial · 2026 · Related
  19. The Coverage Gap in PREVENT: Why Cardiovascular Risk Prediction Needs a Lab-Free Complement · 2026 · Related

Source: OpenAlex (CC0)